In a significant stride towards integrating artificial intelligence with healthcare, technology giant Samsung has announced a partnership with Galeon, a decentralized science (DeSci) and healthcare AI protocol. This collaboration aims to harness data from Samsung’s ultrasound devices to enhance the training of AI models in medical applications.
As per a statement released on Tuesday, Samsung will connect its advanced ultrasound technology with Galeon’s electronic health record (EHR) platform. This innovative platform is already functional across 18 hospitals, including reputable institutions like Rouen University Hospital and Caen University Hospital in France. According to Loïc Brotons, CEO of Galeon, this integration promises to enhance the accessibility of medical data while prioritizing patient privacy.
Brotons elaborated on the operational framework, explaining that while the data used for AI training is not stored on the blockchain, the operations of the AI algorithms themselves are conducted on-chain, allowing for complete traceability. He emphasized that all patient data undergoes anonymization before being utilized, ensuring compliance with privacy regulations.
This strategic collaboration offers healthcare providers a unique opportunity to develop AI models without centralizing sensitive patient information. Each participating institution will maintain control over its own data, thus supporting collaborative algorithm training without compromising individual data integrity.
Healthcare is rapidly becoming a focal point in the decentralized science landscape. Experts believe that the high costs and extensive timeframes involved in traditional drug development are motivating individuals and organizations to pursue decentralized alternatives. Alex Dobrin, an awareness steward at VitaDAO—a decentralized collective aimed at extending human lifespan—shared insights with Cointelegraph regarding the growing trend within the sector.
Highlighting the advancements in DeSci, Dobrin referenced a notable project by HydraDAO, a decentralized autonomous organization that recently claimed success in enabling rats with severed spines to regain mobility within just five days. Such breakthrough discoveries have garnered increased attention from investors in the field.
Moreover, the DeSci ecosystem has seen commendable investment support. Recently, the platform Bio Protocol attracted significant funds, including a $6.9 million investment led by representatives from Maelstrom Fund and Animoca Brands. This follows an earlier fundraising round in late 2024, which saw support from Binance Labs, the venture capital arm of the well-known cryptocurrency exchange.
At the core of many of these initiatives lies the quest for data. Various DeSci platforms are currently under competitive pressure to acquire genetic information from entities like 23andMe, which recently faced financial challenges. This highlights the critical importance of data in shaping future developments in healthcare and decentralized science.
The collaboration between Samsung and Galeon marks a pivotal moment in the convergence of technology and healthcare. By leveraging decentralized approaches, they aim not only to enhance medical data utilization but also to establish a framework that adheres to the highest standards of patient confidentiality. As the DeSci sector continues to evolve, partnerships like this will play a crucial role in driving innovation in healthcare.
